Prot # GS-US-256-0148: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy with GS-5885 Alone or in Combination with GS-9451 with Peginterferon Alfa 2a and Ribavin in Treatment Nave Subjects with Chronic Genot

Project: Research project

Project Details

Effective start/end date7/19/117/19/14


  • PRA Health Sciences (Prot # GS-US-256-0148 // Prot # GS-US-256-0148)
  • Gilead Sciences, Inc (Prot # GS-US-256-0148 // Prot # GS-US-256-0148)